Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellulcar Carcinoma”

3 trials

Showing 3 of 3 results

Testing effectiveness (Phase 2)Looking for participantsNCT07238881
What this trial is testing

Dalpiciclib Plus Camrelizumab for HCC Patients Who Have Previously Received ICI Treatment

Who this might be right for
Hepatocellulcar Carcinoma
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Looking for participantsNCT07501351
What this trial is testing

Efficacy and Safety Comparison Between Intensified Therapy and Conversion Therapy For Advanced HCC After Failure of First-line

Who this might be right for
Hepatocellulcar Carcinoma
Sun Yat-sen University 80
Not applicableStudy completedNCT07537985
What this trial is testing

Efficacy and Safety Comparison Between PD-1 Inhibitor Combined With Lenvatinib or With Regorafenib For UHCC After Failure of First-line Treatment

Who this might be right for
Hepatocellulcar Carcinoma
Sun Yat-sen University 200

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation